How are ROIV long call max profit and max loss calculated?

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the ROIV long call priced from the end-of-day chain at a 30-day expiry (ATM IV 45.50%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$102.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a ROIV long call?

The breakeven for the ROIV long call priced on this page is roughly $36.03 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current ROIV market-implied 1-standard-deviation expected move is approximately 13.04%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current ROIV implied volatility affect this long call?

ROIV ATM IV is at 45.50% with IV rank near 36.78%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

ROIV Long Call Strategy

ROIV (Roivant Sciences Ltd.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company dedicated to discovering and advancing innovative therapeutic drugs. The firm's development pipeline targets a broad spectrum of diseases, including various forms of solid tumors and oncologic malignancies, hematological disorders like sickle cell disease and warm autoimmune hemolytic anemia, as well as rare conditions such as hypophosphatasia. Additionally, Roivant is developing treatments for immunological and dermatological ailments, including psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, thyroid eye diseases, and sarcoidosis, alongside tackling infections like staph aureus bacteremia. Founded in 2014, its operations are based in London, United Kingdom.

ROIV (Roivant Sciences Ltd.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $24.51B, a beta of 1.14 versus the broader market, a 52-week range of 10.705-34.68, average daily share volume of 5.9M, a public-listing history dating back to 2020, approximately 908 full-time employees. These structural characteristics shape how ROIV stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.14 places ROIV roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.

What is a long call on ROIV?

A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.

Current ROIV snapshot

As of June 29, 2026, spot at $34.56, ATM IV 45.50%, IV rank 36.78%, expected move 13.04%. The long call on ROIV below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 18-day expiry.

Why this long call structure on ROIV specifically: ROIV IV at 45.50% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 13.04% (roughly $4.51 on the underlying). The 18-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ROIV expiries trade a higher absolute premium for lower per-day decay. Position sizing on ROIV should anchor to the underlying notional of $34.56 per share and to the trader's directional view on ROIV stock.

ROIV long call setup

The ROIV long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ROIV near $34.56, the first option leg uses a $35.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ROIV chain at a 18-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ROIV shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$35.00	$1.03

ROIV long call risk and reward

Net Premium / Debit: -$102.50
Max Profit (per contract): Unbounded
Max Loss (per contract): -$102.50
Breakeven(s): $36.03
Risk / Reward Ratio: Unbounded

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.

ROIV long call payoff curve

Modeled P&L at expiration across a range of underlying prices for the long call on ROIV. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-100.0%	-$102.50
$7.65	-77.9%	-$102.50
$15.29	-55.8%	-$102.50
$22.93	-33.6%	-$102.50
$30.57	-11.5%	-$102.50
$38.21	+10.6%	+$218.65
$45.85	+32.7%	+$982.68
$53.49	+54.8%	+$1,746.71
$61.13	+76.9%	+$2,510.74
$68.77	+99.0%	+$3,274.77

When traders use long call on ROIV

Long calls on ROIV express a bullish thesis with defined risk; traders use them ahead of ROIV catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.

ROIV thesis for this long call

The market-implied 1-standard-deviation range for ROIV extends from approximately $30.05 on the downside to $39.07 on the upside. A ROIV long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current ROIV IV rank near 36.78% is mid-range against its 1-year distribution, so the IV signal is neutral; the long call thesis on ROIV should anchor more to the directional view and the expected-move geometry. As a Healthcare name, ROIV options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ROIV-specific events.

ROIV long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ROIV positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ROIV alongside the broader basket even when ROIV-specific fundamentals are unchanged. Long-premium structures like a long call on ROIV are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current ROIV chain quotes before placing a trade.

Frequently asked questions

What is a long call on ROIV?: A long call on ROIV is the long call strategy applied to ROIV (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With ROIV stock trading near $34.56, the strikes shown on this page are snapped to the nearest listed ROIV chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are ROIV long call max profit and max loss calculated?: Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the ROIV long call priced from the end-of-day chain at a 30-day expiry (ATM IV 45.50%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$102.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a ROIV long call?: The breakeven for the ROIV long call priced on this page is roughly $36.03 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current ROIV market-implied 1-standard-deviation expected move is approximately 13.04%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long call on ROIV?: Long calls on ROIV express a bullish thesis with defined risk; traders use them ahead of ROIV catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
How does current ROIV implied volatility affect this long call?: ROIV ATM IV is at 45.50% with IV rank near 36.78%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.